CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Grant or award Director acquired 75,572 shares (grant or award)
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- 8-K Event Exit or restructuring costs
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale President and CEO sold 3,331 shares at $7.00 ($23,307)
- 4 Open-market sale EVP, CFO and COO sold 1,211 shares at $7.00 ($8,473)
- 4 Open-market sale EVP, Chief Regulatory Officer sold 1,059 shares at $7.00 ($7,410)
Page 6 of 57 · 1,133 filings